A substantial number of patients admitted to the ICU because of an acute illness,
complicated surgery, severe trauma, or burn injury will develop a de novo form of muscle …

Critical illness polyneuropathies (CIP) and myopathies (CIM) are common complications of
critical illness. Several weakness syndromes are summarized under the term intensive care …

Intensive care unit‐acquired weakness (ICUAW) occurs frequently in the context of critical
illness without alternative plausible cause and specific treatment options, and it is important …

Intensive care unit-acquired weakness, the main clinical sign of critical illness
neuromyopathy, is an increasingly recognized cause of prolonged mechanical ventilation …

Critical illness, more precisely defined as the systemic inflammatory response syndrome
(SIRS), occurs in 20%–50% of patients who have been on mechanical ventilation for more …

Critical illness polyneuropathy (CIP) and myopathy (CIM) are major complications of severe
critical illness and its management. CIP/CIM prolongs weaning from mechanical ventilation …

An acute myopathy of intensive care occurs in critically ill patients treated with intravenous
corticosteroids and neuromuscular junction‐blocking agents. The full clinicopathological …

Objective: Long-term treatment with nondepolarizing neuromuscular blocking agents and
corticosteroids in the intensive care unit is not benign, and an increasing number of patients …

Objective: To investigate whether the combination of intravenous immunoglobulin (IVIg) with
prednisone improves muscle strength and alters endomysial inflammation in patients with …

Neuromuscular complications of critical illness are common, and can be severe and
persistent, with substantial impairment in physical function and long-term quality of life …